Observational analysis reveals improved survival linked to Vγ9Vδ2 T cells in triple-negative breast cancer patients, suggesting immunotherapy options.
Vγ9Vδ2 T cells are associated with better survival in TNBC (related to Figure 1).
No takes yet. Share an insight, caveat, or question.
Fattori et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: